Competition for HPV testing just got more intense with the announcement that Roche Diagnostics has obtained rights to the Human Papillomavirus (HPV) patent portfolio owned by Institut Pasteur in France. It intends to develop an HPV test that would compete with Digene Corporation’s HPV test. Digene currently holds a strong market position because it owns …
“June 24, 2002 Intelligence: Late Breaking Lab News” Read More »
